megestrol acetate has been researched along with Endometrial Hyperplasia in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.76) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 13 (38.24) | 24.3611 |
| 2020's | 10 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, HC; Kung, FT; Lan, J; Lan, KC; Lin, H; Ou, YC; Tsai, YC; Wu, CH | 1 |
| Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
| Chen, X; Guan, J; Liao, J; Luo, X; Ma, F; Ning, C; Shan, W; Shao, W; Wu, P; Xu, Z; Yang, B; Zhang, H; Zhou, S; Zhu, Q | 1 |
| Chen, XJ; Cheng, YL; Du, Y; Guan, J; Gulinazi, Y; Liu, J; Luo, XZ; Ma, FH; Ning, CC; Shan, WW; Sun, L; Yang, BY; Yu, M; Zhang, HW; Zhu, Q | 1 |
| Atiomo, W | 1 |
| Gowri, V; Rawahi, TA; Shikeli, S | 1 |
| Aghajani, R; Arab, M; Ghahghaei-Nezamabadi, A; Khalagi, K; Sadeghi, S; Tehranian, A | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Catena, U; Fanfani, F; Masciullo, V; Moroni, R; Scambia, G; Trivellizzi, N; Zannoni, G | 1 |
| Mirmohammadkhanai, M; Moradan, S; Nikkhah, N | 1 |
| Atiomo, W; Clement, NS; Mulvaney, CA; Oliver, TR; Sanner, JR; Shiwani, H | 1 |
| Chen, X; Du, Y; Luo, X; Xie, L; Yang, B; Zhang, H; Zhu, Q | 1 |
| Chen, X; Luo, X; Ning, C; Shan, W; Shi, Y; Xie, B; Xie, L; Xu, Y; Yang, B; Zhang, H; Zhu, Q | 1 |
| Liu, H; Wang, H; Wang, J; Wang, Y; Zhou, R | 1 |
| Cao, DY; Cheng, NH; Deng, CY; He, FF; Huang, HF; Shen, K; Sun, ZY; Yang, JX; Yu, M; Yu, Q | 1 |
| Akdogan, A; Akman, L; Dikmen, Y; Ozsaran, A; Sahin, G; Tavmergen Goker, EN; Tavmergen, E; Terek, MC | 1 |
| Clarke, BA; Feigenberg, T; Ferguson, SE; Gien, LT; Ismiil, N; Laframboise, S; Massey, C; Simpson, AN | 1 |
| Kim, MK; Seong, SJ | 1 |
| Chen, X; Gu, C; Luo, X; Ning, C; Shan, W; Wang, C; Zhang, Z; Zhou, Q | 1 |
| Bidadi, S; Foroughi, M; Ghojazadeh, M; Melli, MS; Tabrizi, AD | 1 |
| Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y | 1 |
| Lin, JF; Shen, ZQ; Zhu, HT | 1 |
| Baiocco, E; Carosi, M; Corrado, G; Vizza, E | 1 |
| Han, AR; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Kwon, YS; Nam, JH | 1 |
| Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
| Chen, YM; Lee, CS; Wright, PJ | 1 |
| Edman, CD; Forney, JP; Gal, D; Vellios, F | 1 |
| Rose, PG | 1 |
| Amezcua, CA; Felix, JC; Lu, JJ; Stanczyk, FZ; Zheng, W | 1 |
| Dikmen, Y; Erhan, Y; Güven, M; Itil, IM; Ozsaran, AA; Terek, MC | 1 |
| Canetta, R; Kelley, S; Nicaise, C; Rozencweig, M; Schacter, L; Smaldone, L | 1 |
| Gal, D | 1 |
| Wentz, WB | 1 |
2 review(s) available for megestrol acetate and Endometrial Hyperplasia
| Article | Year |
|---|---|
Metformin for endometrial hyperplasia.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Megestrol Acetate; Metformin; Middle Aged; Precancerous Conditions; Randomized Controlled Trials as Topic; Recurrence; Uterine Hemorrhage; Uterine Neoplasms | 2017 |
Megestrol acetate: clinical experience.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anorexia; Breast Neoplasms; Cachexia; Carcinoma, Renal Cell; Contraceptive Agents, Male; Contraceptives, Oral; Endometrial Hyperplasia; Female; Humans; Kidney Neoplasms; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Ovarian Neoplasms; Prostatic Hyperplasia; Prostatic Neoplasms; Rabbits; Tamoxifen; Uterine Neoplasms | 1989 |
7 trial(s) available for megestrol acetate and Endometrial Hyperplasia
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study.
Topics: China; Endometrial Hyperplasia; Female; Fertility; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Pregnancy; Prospective Studies | 2023 |
Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; China; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Metformin; Middle Aged; Treatment Outcome; Young Adult | 2020 |
The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Metformin | 2021 |
Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Female; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Pilot Projects; Triazoles | 2017 |
Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metabolic Syndrome; Metformin; Pilot Projects; Receptors, Estrogen; Receptors, Progesterone; Single-Blind Method; Treatment Outcome | 2014 |
Antiproliferative effect of metformin on the endometrium--a clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Atrophy; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Metrorrhagia | 2014 |
25 other study(ies) available for megestrol acetate and Endometrial Hyperplasia
| Article | Year |
|---|---|
The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Pregnancy; Progestins; Retrospective Studies; Treatment Outcome | 2021 |
Is there any move to use metformin for endometrial hyperplasia in routine clinical practice?
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin | 2020 |
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Treatment Outcome; Young Adult | 2020 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
Topics: Abortion, Spontaneous; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Hysteroscopy; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Rate; Prognosis; Prospective Studies | 2021 |
Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients.
Topics: Adult; Body Mass Index; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Insulin Resistance; Megestrol Acetate; Middle Aged; Overweight; Retrospective Studies; Time Factors; Young Adult | 2018 |
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Megestrol Acetate; Metformin; Middle Aged; Progestins; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Rate; Retrospective Studies; Treatment Outcome | 2019 |
[Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Medroxyprogesterone; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Reproductive outcomes after progestin therapy in infertile women with endometrial atypical hyperplasia.
Topics: Adult; Endometrial Hyperplasia; Female; Fertilization in Vitro; Humans; Infertility, Female; Megestrol Acetate; Pregnancy; Progestins; Retrospective Studies; Treatment Outcome | 2013 |
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Organ Sparing Treatments; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome | 2014 |
Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
Topics: Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin | 2014 |
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
Topics: Adult; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Progestins | 2008 |
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Hysteroscopy; Laparoscopy; Megestrol Acetate; Neoplasm Staging; Ovariectomy; Ovulation Induction; Precancerous Conditions; Pregnancy; Radiotherapy, Adjuvant; Treatment Failure | 2008 |
Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Reproductive Techniques, Assisted; Retrospective Studies | 2009 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
The roles of progestagen and uterine irritant in the maintenance of cystic endometrial hyperplasia in the canine uterus.
Topics: Animals; Dog Diseases; Dogs; Endometrial Hyperplasia; Estradiol; Estrous Cycle; Female; Histocytochemistry; Irritants; Megestrol Acetate; Ovariectomy; Progestins; Silk; Sutures | 2006 |
Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
Topics: Adenocarcinoma; Carcinoma in Situ; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Time Factors; Uterine Neoplasms | 1983 |
Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
Topics: Adenocarcinoma; Adenoma; Antineoplastic Agents; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperglycemia; Insulin; Megestrol; Megestrol Acetate; Middle Aged | 1996 |
Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
Topics: Adult; Apoptosis; Cell Count; Endometrial Hyperplasia; Endometrium; Female; Humans; In Situ Nick-End Labeling; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Paraffin Embedding; Progesterone Congeners; Progestins; Tumor Cells, Cultured | 2000 |
Metabolic effects associated with high-dose continuous megestrol acetate administration in the treatment of endometrial pathology.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endometrial Hyperplasia; Fasting; Female; Food; Humans; Lipids; Megestrol Acetate; Middle Aged; Postmenopause; Triglycerides; Uterine Hemorrhage; Weight Gain | 2001 |
Hormonal therapy for lesions of the endometrium.
Topics: Body Weight; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Megestrol; Megestrol Acetate; Recurrence | 1986 |
Progestin therapy in lesions of the endometrium.
Topics: Adenocarcinoma; Adult; Endometrial Hyperplasia; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1985 |